Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and miceRyan G. Lim, Dhruv Sareen, Lisa Salazar et al.|Nature Neuroscience|2017Cited by 235
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell linesEmily G. Baxi, Krishna Raja, Terri G. Thompson et al.|Nature Neuroscience|2022Cited by 160
Bioenergetic deficits in Huntington’s disease iPSC-derived neural cells and rescue with glycolytic metabolitesAmanda J. Kedaigle, Christopher A. Ross, Ernest Fraenkel et al.|Human Molecular Genetics|2019Cited by 60
PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington’s diseaseEva L. Morozko, Leslie M. Thompson, Alice Lau et al.|Proceedings of the National Academy of Sciences|2021Cited by 56
NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotencyAndrea Matlock, Vineet Vaibhav, Ronald J. Holewinski et al.|Scientific Data|2023Cited by 11